# BioNTech SE: Form 6-K, filed Feb 24, 2023

- Company: [BioNTech SE](/companies/bntx.md) (CIK 1776985)
- Form: 6-K
- Filed: 2023-02-24
- Accepted by EDGAR: Feb 24, 2023, 08:58 ET
- Period: 2023-02-24
- Accession: 0001776985-23-000009
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1776985/000177698523000009/form6-kcovidx19bivalentsbl.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1776985/000177698523000009/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1776985/000177698523000009/form6-kcovidx19bivalentsbl.htm

Filed Feb 24, 2023.
Source: SEC EDGAR, the filing index for accession 0001776985-23-000009. Last ingested by Listed: Nov 10, 2026, 16:47 ET. No prices; not investment advice.
